Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases

NCT06416709 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Injury

Interventions

DRUG: mesenchymal stem cells
OTHER: saline

Sponsor

Cell Energy Life Sciences Group Co. LTD

Collaborators

[object Object]